RSVP
LLY icon

Ramsay Stattman Vela & Price’s Eli Lilly LLY Stock Holding History

Ramsay Stattman Vela & Price’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-191
Closed -$205K – 83
2025
Q4 		$205K Buy
+191
New +$183K 0.04% 80

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ramsay Stattman Vela & Price's LLY Position: Q1 2026 in Review

Ramsay Stattman Vela & Price sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 191 shares — an estimated $205K sold.

Ramsay Stattman Vela & Price first reported a position in LLY in Q4 2025 and held it in 1 quarter. The position peaked at $205K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Ramsay Stattman Vela & Price reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Ramsay Stattman Vela & Price sold 191 Eli Lilly shares in Q1 2026, an estimated $205K.
  • Ramsay Stattman Vela & Price first reported a position in Eli Lilly in Q4 2025 and held it in 1 quarter.
  • Ramsay Stattman Vela & Price's Eli Lilly position peaked at $205K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ramsay Stattman Vela & Price's 13F filing for Q1 2026, filed 30 Apr 2026.